Decreased Antibody Responses to Ad26.COV2.S Relative to SARS-CoV-2 mRNA Vaccines in Patients With Inflammatory Bowel Disease

Affiliations

• ¹ Inflammatory Bowel and Immunobiology Research Institute, Karsh Division of Digestive and Liver Diseases, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California.
• ² Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, California.
• ³ Applied Research and Technology, Abbott Diagnostics, Abbott Park, Illinois.
• ⁴ Inflammatory Bowel and Immunobiology Research Institute, Karsh Division of Digestive and Liver Diseases, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California. Electronic address: gil.melmed@cshs.org.
• ⁵ Smidt Heart Institute, Department of Medicine, Cedars-Sinai, Los Angeles, California.
• ⁶ Samual Oschin Comprehensive Cancer Center, Cedars-Sinai, Los Angeles, California.
• ⁷ University of California, San Diego, California.
• ⁸ Sibley Memorial Hospital, Johns Hopkins, Washington, District of Columbia.
• ⁹ Swedish Hospital, Seattle, Washington.
• ¹⁰ Capital Digestive Care, Chevy Chase, Maryland.
• ¹¹ University of Utah, Salt Lake City, Utah.
• ¹² UT Southwestern, Dallas, Texas.
• ¹³ Center for Rheumatology, Los Angeles, California.
• ¹⁴ Baylor College of Medicine, Houston, Texas.
• ¹⁵ Hoag Hospital, Newport Beach, California.
• ¹⁶ Johns Hopkins Hospital, Baltimore, Maryland.
• ¹⁷ The Oregon Clinic, Portland, Oregon.
• ¹⁸ Medstar-Georgetown, Washington, District of Columbia.
• ¹⁹ Saratoga-Schenectady Gastroenterology, Saratoga Springs, New York.
• ²⁰ University of California, Irvine, California.
• ²¹ The Mayo Clinic, Rochester, Minnesota.
• ²² Keck Medicine of University of Southern California, Los Angeles, California.
• ²³ Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire.
• ²⁴ Atlanta Gastroenterology Associates, Atlanta, Georgia.
• ²⁵ Gastro One, Germantown, Tennessee.